Certara Services Archives

Press Release

Certara Reports Second Quarter 2025 Financial Results

RADNOR, PA— August 6, 2025-- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,…

CertaraAugust 6, 2025

Blog

Replacing Traditional TQT Studies with Model-Based Concentration-QTc (C-QTc) Analysis for Cardiovascular Safety in Drug Development

Learn how our experts use concentration-QTc (C-QTc) analysis to replace costly TQT studies, streamline QT…

CertaraAugust 6, 2025

On-Demand Webinar

Understanding Antibody-Drug Conjugates (ADCs) Pharmacokinetics From NCA to Population PK Approaches

CertaraAugust 1, 2025

Blog

Machine Learning (ML) in healthcare

Learn about 3 distinct examples of machine learning (ML) in healthcare that utilize different techniques…

CertaraAugust 1, 2025

Blog

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…

CertaraJuly 31, 2025

Case Study

Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development

Certara supported DMD drug development for Givinostat, helping Italfarmaco with pharmacometric and regulatory strategy.

CertaraJuly 29, 2025

On-Demand Webinar

Insights Without Animals: Leveraging Human-on-a-Chip & PBPK Modeling

CertaraJuly 29, 2025

On-Demand Webinar

MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines

Learn how clinical pharmacologists and modeling experts collaborate to improve preclinical-to-clinical translation.

CertaraJuly 29, 2025

Blog

ADNCA Explained: The Next Generation of Non-Compartmental Analysis and the Top Questions Answered

ADNCA is transforming non-compartmental analysis by standardizing workflows, enhancing regulatory confidence, and enabling scalable automation.…

CertaraJuly 23, 2025

Press Coverage

Streamline Your Regulatory Writing with Process Infographics

Discover how process infographics successfully enhance regulatory writing by simplifying complex workflows, improving compliance documentation,…

CertaraJuly 17, 2025

Certara Services

Certara Reports Second Quarter 2025 Financial Results

Replacing Traditional TQT Studies with Model-Based Concentration-QTc (C-QTc) Analysis for Cardiovascular Safety in Drug Development

Understanding Antibody-Drug Conjugates (ADCs) Pharmacokinetics From NCA to Population PK Approaches

Machine Learning (ML) in healthcare

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development

Insights Without Animals: Leveraging Human-on-a-Chip & PBPK Modeling

MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines

ADNCA Explained: The Next Generation of Non-Compartmental Analysis and the Top Questions Answered

Streamline Your Regulatory Writing with Process Infographics

Newsletter sign up

Quick links

Solutions

Contact